We have located links that may give you full text access.
CLINICAL TRIAL
COMPARATIVE STUDY
JOURNAL ARTICLE
RESEARCH SUPPORT, U.S. GOV'T, P.H.S.
Asparaginase and amino acids in cancer therapeutics. Cancer and Leukemia Group B Investigators.
Asparaginase was found ineffective in improving induction frequency of acute lymphocytic leukemia of children from vincristine and prednisone, but prolonged remission duration. Prolongation of remission duration was accomplished more effectively and at lower toxic cost by administration of asparaginase after the vincristine and prednisone treatment had been completed. Asparaginase is markedly more effective against human leukemia T-cells in vitro than against several types of B-lymphocytes. This is consistent with in vivo experience. Leukemic T-cells resistant to asparaginase have been induced in vitro. Deficiency of other amino acids causes absolute cessation of RNA biosynthesis, constituting evidence for other amino acid targets critical to leukemic cell survival.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app